Komori
General Meetings of Shareholders2796Pharmarise Holdings CorporationRetail

Notice Regarding the Results of the Counting of Voting Rights Exercised at the 40th Annual General Meeting of Shareholders

The voting results for the 40th Annual General Meeting of Shareholders were announced, and the proposals for the appropriation of surplus and the election of 9 directors and 1 Audit & Supervisory Board member were all approved as proposed.

Worth reading
45Recurring
Scored from 2 of 4 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
80.86
% (voting rights exercised)
Wording
Definitive
How definitive the wording is.

Resolutions for the General Meeting of Shareholders

Annual (40th fiscal year)
2026
Aug 28
Date and time(start time: Not disclosed)
Matters for resolution3 items
  1. Disposition of surplus

  2. Election of 9 directors

  3. Election of 1 Audit & Supervisory Board member

Shareholder Proposal

None (company proposals only)

A shareholder proposal is a resolution submitted by a shareholder, rather than by the company.
Director nominee9 candidates (number of new candidates: Not disclosed; number of outside candidates: Not disclosed)
Resolutions for the General Meeting of Shareholders
ItemDetails
Type of shareholders' meetingAnnual (40th fiscal year)
Date and time28 August 2026 (start time: Not disclosed)
Matters for resolutionProposal No. 1: Disposition of surplus, Proposal 2: Election of 9 directors, Proposal No. 3: Election of 1 Audit & Supervisory Board member
Shareholder ProposalNone (company proposals only)
Director nominee9 candidates (number of new candidates: Not disclosed; number of outside candidates: Not disclosed)
Items this document does not state (1)
Percentage voting in favor

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The votes exercised in advance and the voting rights of certain shareholders whose approval or disapproval could be confirmed on the day of the meeting were tabulated. As a result, each proposal satisfied the requirements for approval, and the resolutions were validly adopted in accordance with the Companies Act. Voting rights for which approval or disapproval could not be confirmed were not included.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Results of the Counting of Voting Rights Exercised at the 40th Annual General Meeting of Shareholders | Pharmarise Holdings Corporation (2796) timely disclosure | Komori